AAP Implantate

Berlin, Germany Founded: 1990 • Age: 36 yrs Acquired By Keensight Capital
Developer, manufactures and markets trauma and biomaterials products for orthopedics
Request Access

About AAP Implantate

AAP Implantate is a company based in Berlin (Germany) founded in 1990 was acquired by Keensight Capital in March 2016.. The company has 93 employees as of December 31, 2024. AAP Implantate offers products and services including LOQTEQ® Implants and ReproBone®. AAP Implantate operates in a competitive market with competitors including Treace Medical Concepts, Bioretec, Loci Orthopaedics, IlluminOss Medical and Stanmore Implants, among others.

  • Headquarter Berlin, Germany
  • Employees 93 as on 31 Dec, 2024
  • Stage Public
  • Sectors
    Healthcare
  • Email
    ***********
  • Phone
    *********
  • Website
    *********
  • Social
    *********
  • Legal Name Aap Implantate Ag
Operational Areas
Healthcare → Healthcare Products & Supplies
Key Metrics
  • Annual Revenue
    $12.67 M (USD)
    6.32
    as on Dec 31, 2024
  • Net Profit
    $-3.77 M (USD)
    54.41
    as on Dec 31, 2024
  • EBITDA
    $-1.8 M (USD)
    59.49
    as on Dec 31, 2024
  • Latest Funding Round
  • Investors
  • Employee Count
    93

    as on Dec 31, 2024

  • Acquired by
    Keensight Capital

    (Mar 22, 2016)

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

IPO & Listings of AAP Implantate

AAP Implantate is a publicly listed company on the XETR with ticker symbol AAQ1 in Germany, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.

Exchange: XETR · Ticker: AAQ1 . Sector: Health technology · Germany

Products & Services of AAP Implantate

AAP Implantate offers a comprehensive portfolio of products and services, including LOQTEQ® Implants and ReproBone®. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.

Primary

Provides fracture compression and locking for orthopedic surgery.

Offers solutions for bone regeneration in medical procedures.

Funding Insights of AAP Implantate

  • Total Funding
  • Total Rounds 2
  • Last Round
  • First Round
  • Investors Count
Date Amount Transaction Name Valuation Lead Investors Investors
Mar, 2023 Amount Post-IPO - AAP Implantate Valuation

investors

Aug, 2004 Amount Post-IPO - AAP Implantate Valuation

investors

Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in AAP Implantate

AAP Implantate has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Keensight Capital. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Institutional
Investor Description Founded Year Domain Location
Keensight Capital is recognized as a European Growth Buyout investor.
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by AAP Implantate

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016

Financial Statements - AAP Implantate

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Aap Implantate Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of AAP Implantate

AAP Implantate operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Treace Medical Concepts, Bioretec, Loci Orthopaedics, IlluminOss Medical and Stanmore Implants, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Orthopedic foot and ankle correction systems are developed and offered.
domain founded_year HQ Location
Provider of bioabsorbable, bioactive and drug-releasing surgical implants
domain founded_year HQ Location
Thumb implant for thumb base arthritis
domain founded_year HQ Location
Minimally invasive orthopedic systems for bone fracture stabilization are developed.
domain founded_year HQ Location
Modular implants for limb sparing and complex primary and revision joint replacement
domain founded_year HQ Location
Metal implants for orthopedic fracture fixation are developed and marketed.
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Frequently Asked Questions about AAP Implantate

When was AAP Implantate founded?

AAP Implantate was founded in 1990 and raised its 1st funding round 14 years after it was founded.

Where is AAP Implantate located?

AAP Implantate is headquartered in Berlin, Germany. It is registered at Berlin, Berlin, Germany.

Who is the current CEO of AAP Implantate?

Uwe Ahrens is the current CEO of AAP Implantate.

How many employees does AAP Implantate have?

As of Dec 31, 2024, the latest employee count at AAP Implantate is 93.

What is the annual revenue of AAP Implantate?

Annual revenue of AAP Implantate is $12.67M as on Dec 31, 2024.

What does AAP Implantate do?

The company was founded in 1990 and is based in Berlin, Germany. Operations focus on the orthopedics sector, where trauma and biomaterials products are developed, manufactured, and marketed. The trauma portfolio includes the LOQTEQ anatomical plating system, cannulated screws, and standard plates and screws. Antibacterial silver-coating is incorporated to address implant-related infections, while magnesium-based biodegradable implants are also offered.

Who are the top competitors of AAP Implantate?

AAP Implantate's top competitors include Treace Medical Concepts, Loci Orthopaedics and Bioretec.

What products or services does AAP Implantate offer?

AAP Implantate offers LOQTEQ® Implants and ReproBone®.

Is AAP Implantate publicly traded?

Yes, AAP Implantate is publicly traded on XETR under the ticker symbol AAQ1.

Who are AAP Implantate's investors?

AAP Implantate has 1 investor. Key investors include Keensight Capital.

What is AAP Implantate's ticker symbol?

The ticker symbol of AAP Implantate is AAQ1 on XETR.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available